On Monday, Aurobindo Pharma has announced the receipt of final approval from the US health regulator for manufacturing and marketing its generic versions of Parkinson’s disease treatment drug Entacapone tablets and anti-biotics Azithromycin in the American market.

According to a statement by the company, The approval by the US Food and Drug Administration (USFDA) to manufacture and market Entacapone Tablets is for strength of 200mg and product will be launched soon.

Read useful tips on Indian share market